StockData
MediciNova Inc logo

MediciNova Inc (MNOV) stock

MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.33−0.01 (-0.75%)

Close on Nov 18, 2026Market cap $65.46MP/E –Yield –

MediciNova price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

MediciNova's price to sales ratio was 75.4× on Nov 11, 2026, against 66.2× a year earlier. Over the last 2 years it ranged from 7.9× to 469.4×, with a median of 76.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202675.4×+12.1
2024Apr 30, 202463.3×+30.8
2022Apr 29, 202232.4×+24.3
2014Jul 31, 20148.1×−443.1
2013Oct 31, 2013451.2×–

More MediciNova figures

See a number that looks wrong?